BTG outlines strategy for building sustainability
This article was originally published in Scrip
Executive Summary
BTG CEO Louise Makin believes pursuit of the company's three-pronged strategy will return the company to sustainable profitability. Having reported three consecutive years of profit through to 31 March 2008, the UK-based specialty pharma company reported losses in 2009 and 2011, but has just announced pre-tax profits of £23 million, against the £10.8 million loss in the year ending 31 March 2011. Concomitantly, revenue increased by 77% to £197 million compared with £111 million in the same period last time.